financetom
Business
financetom
/
Business
/
WESCO International Q3 Adjusted Earnings, Sales Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WESCO International Q3 Adjusted Earnings, Sales Decline
Oct 31, 2024 1:11 PM

07:10 AM EDT, 10/31/2024 (MT Newswires) -- WESCO International ( WCC ) reported Q3 adjusted earnings Thursday of $3.58 per diluted share, down from $4.49 a year earlier.

Analysts polled by Capital IQ expected $3.24.

Net sales for the quarter ended Sept. 30 were $5.49 billion, down from $5.64 billion a year earlier.

Analysts surveyed by Capital IQ expected $5.46 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing in talks with US defense department on impact of guilty plea - source
Boeing in talks with US defense department on impact of guilty plea - source
Jul 8, 2024
WASHINGTON (Reuters) - Boeing is in talks with the U.S. Defense Department over how the planemaker's planned guilty plea could affect its extensive government contracts, a person briefed on the matter said. Late on Sunday, the Justice Department said in a court filing that Boeing had agreed to plead guilty to a criminal fraud conspiracy charge to resolve an investigation...
Preview: Qmmm Holdings Limited Set To IPO Tomorrow
Preview: Qmmm Holdings Limited Set To IPO Tomorrow
Jul 8, 2024
QMMM Holdings Limited (NASDAQ:QMMM) IPO will take place July, 09 on the NASDAQ exchange under the ticker QMMM. The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on January 05, 2025. See also: Benzinga IPO Calendar About QMMM Holdings Limited QMMM Holdings Limited is a holding company...
Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe
Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe
Jul 8, 2024
11:20 AM EDT, 07/08/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said Monday that the European Commission has approved the marketing of its oral treatment Livmarli for progressive familial intrahepatic cholestasis, or PFIC, in patients aged 3 months or more. PFIC is a disorder that causes progressive liver disease. The approval is based on a phase 3 study, which...
China has shown 'utmost sincerity' over China-EU EV tariff talks, ministry says
China has shown 'utmost sincerity' over China-EU EV tariff talks, ministry says
Jul 8, 2024
BEIJING (Reuters) - China has shown the utmost sincerity over consultations relating to a European Union investigation into electric vehicle subsidies, and a comment attributed to an EU official is grossly inconsistent with the facts, the commerce ministry said on Monday. Jorge Toledo, the EU's ambassador to China, was quoted by media as saying Beijing had only recently responded to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved